New hope for Tough-to-Treat lung cancer? early trial tests novel drug
Disease control
Recruiting now
This early-stage study is testing a new drug called SNB-101 in people with advanced small cell lung cancer that has worsened after standard treatment. The main goals are to find a safe dose, see how the body processes the drug, and check for any early signs that it might help con…
Phase: PHASE1, PHASE2 • Sponsor: SN BioScience • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC